Human papillomavirus vaccine uptake among males 11-26 years in United States: Findings from the national health and nutrition examination survey, 2011-2012

Vaccine

Volumn 32, Issue 49, 2014, Pages 6655-6658

  Pierre Victor, Dudith ^a   Mukherjee, Soumyadeep ^a   Bahelah, Raed ^a   Madhivanan, Purnima ^a  

^a FLORIDA INTERNATIONAL UNIVERSITY   (United States)

Author keywords

Completion; HPV; Males; Vaccination; Vaccine initiation

Indexed keywords

WART VIRUS VACCINE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONDYLOMA ACUMINATUM; GROUPS BY AGE; HEALTH CARE UTILIZATION; HEALTH PROMOTION; HEALTH SURVEY; HUMAN; MALE; PRIORITY JOURNAL; SAMPLING; SCHOOL CHILD; UNITED STATES; VACCINATION; IMMUNOLOGY; NUTRITION; PAPILLOMAVIRUS INFECTIONS; UTILIZATION; YOUNG ADULT;

ADOLESCENT; ADULT; CHILD; HUMANS; MALE; NUTRITION SURVEYS; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; UNITED STATES; VACCINATION; YOUNG ADULT;

EID: 84922599047     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2014.09.044     Document Type: Article

References (22)

1. Cates W.J. Estimates of the incidence and prevalence of sexually transmitted diseases in the United States: American Social Health Association Panel. Sex Transm Dis 1999, 26(4 suppl):S2-S7.
2. Weinstock H., Berman S., Cates W.J. Sexually transmitted diseases among American youth: Incidence and prevalence estimates, 2000. Perspect Sex Reprod Health 2004, 36(1):6-10.
3. Endo M., Yamashita T., Jin H.-Y., Akutsu Y., Jimbow K. Detection of human papillomavirus type 16 in bowenoid papulosis and nonbowenoid tissues. Int J Dermatol 2003, 42:474-476. Available at: http://www.ncbi.nlm.nih.gov/pubmed/12786880.
4. Bosch F.X., Lorincz A., Muñoz N., Meijer C.J.L.M., Shah K.V. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002, 55:244-265.
5. Jones R.W., Rowan D.M., Stewart A.W. Vulvar intraepithelial neoplasia: aspects of the natural history and outcome in 405 women. Obstet Gynecol 2005, 106(6):1319-1326.
6. Gissmann L., zur Hausen H. Partial characterization of viral DNA from human genital warts (Condylomata acuminata). Int J Cancer 1980, 25:605-609.
7. Gillison M.L., Chaturvedi A.K., Lowy D.R. HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women. Cancer 2008, 113(10 Suppl):3036-3046. 10.1002/cncr.23764.
8. Goel M.S., Wee C.C., McCarthy E.P., Davis R.B., Ngo-Metzger Q., Phillips R.S. Racial and ethnic disparities in cancer screening: the importance of foreign birth as a barrier to care. J Gen Intern Med 2003, 18(12):1028-1035. Available at: http://www.pubmedcentral.nih.gov/articlerender.fcgi? artid=1494963 &tool=pmcentrez&rendertype=abstract.
9. Feoli-Fonseca J.C., Oligny L.L., Brochu P., Simard P., Falconi S., Yotov W.V. Human papillomavirus (HPV) study of 691 pathological specimens from Quebec by PCR-direct sequencing approach. J Med Virol 2001, 63:284-292. Available at: http://www.ncbi.nlm.nih.gov/pubmed/11241459.
10. Muñoz N., Bosch F.X., de Sanjosé S., et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003, 348(6):518-527. 10.1056/NEJMoa021641.
11. Centers for Disease Control and Prevention FDA licensure of bivalent human papillomirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP). Morb Mortal Wkly Rep 2010, 59(20):625-629.
12. Centers for Disease Control and Prevention Recommendations on the use of quadrivalent human papillomavirus vaccine in males - Advisory Committee on Immunization Practices (ACIP), 2011. Morb Mortal Wkly Rep 2011, 60(50):1704-1708. Available at: http://www.ncbi.nlm.nih.gov/pubmed/22189891.
13. Reiter P.L., Gilkey M.B., Brewer N.T. HPV vaccination among adolescent males: results from the National Immunization Survey-Teen. Vaccine 2013, 31(26):2816-2821. 10.1016/j.vaccine.2013.04.010.
14. Gilkey M.B., Moss J.L., Mcree A., Brewer N.T. Do correlates of HPV vaccine initiation differ between adolescent boys and girls?. Vaccine 2012, 30:5928-5934. 10.1016/j.vaccine.2012.07.045.
15. Reiter P.L., McRee A.-L., Kadis J.a, Brewer N.T. HPV vaccine and adolescent males. Vaccine 2011, 29(34):5595-5602. 10.1016/j.vaccine.2011.06.020.
16. National Centers for Health Statistics. NHANES Survey Design; 2013. Available at: [accessed 11.05.14]. http://www.cdc.gov/nchs/tutorials/nhanes/SurveyDesign/SampleDesign/intro.htm.
17. National Centers for Health Statistics. 2011-2012 National Health and Nutrition Examination Survey (NHANES): Survey questionnaires, examination components and laboratory components 2011-2012; 2012. Available at: [accessed 10.10.13]. http://www.cdc.gov/nchs/nhanes/nhanes2011-2012/questexam%2011_12.htm.
18. National Centers for Health Statistics. NHANES response rates and population totals; 2013. Available at: [accessed 20.11.13]. http://www.cdc.gov/nchs/nhanes/response_rates.CPS.htm.
19. StataCorp. Stata Statistical Software: Release 13; 2013.
20. Laz T.H., Rahman M., Berenson A.B. An update on human papillomavirus vaccine uptake among 11-17 year old girls in the United States: National Health Interview Survey, 2010. Vaccine 2012, 30:3534-3540. 10.1016/j.vaccine.2012.03.067.
21. Niccolai L.M., Mehta N.R., Hadler J.L. Racial/ethnic and poverty disparities in human papillomavirus vaccination completion. Am J Prev Med 2011, 41(4):428-433. 10.1016/j.amepre.2011.06.032.
22. Taylor L.D., Hariri S., Sternberg M., Dunne E.F., Markowitz L.E. Human papillomavirus vaccine coverage in the United States, National Health and Nutrition Examination Survey, 2007-2008. Prev Med (Baltim) 2011, 52:398-400. 10.1016/j.ypmed.2010.11.006.